Skip to main content
. 2013 Feb 26;17(2):168–178. doi: 10.1111/petr.12048

Fig. 2.

Fig. 2

(a) Acute rejection in 101 alemtuzumab treated patients; (b) patients stratified by time of transplantation. Incidence of clinical rejection depicted by dotted lines. (c) Mean Banff scores for chronic interstitial fibrosis, tubular atrophy, arteriolar hyalinosis, chronic fibrointimal thickening, and chronic glomerulopathy.